Sjs Investment Consulting Inc. Pacira Bio Sciences, Inc. Transaction History

Sjs Investment Consulting Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	BUY	$26.32 - $34.31 $26 - $34	1 Added 25.0%	5 $0
Q3 2023 Oct 17, 2023	SELL	$30.68 - $40.09 $30 - $40	-1 Reduced 20.0%	4 $0
Q2 2023 Jul 13, 2023	SELL	$36.12 - $47.5 $36 - $47	-1 Reduced 16.67%	5 $0
Q1 2023 Apr 20, 2023	BUY	$35.53 - $43.38 $35 - $43	1 Added 20.0%	6 $0
Q4 2022 Jan 23, 2023	BUY	$38.19 - $57.45 $38 - $57	1 Added 25.0%	5 $0
Q3 2022 Oct 13, 2022	SELL	$51.24 - $58.89 $8,147 - $9,363	-159 Reduced 97.55%	4 $0
Q1 2022 May 05, 2022	BUY	$60.03 - $76.49 $60 - $76	1 Added 0.62%	163 $12,000
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $7,771 - $10,078	162 New	162 $10,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.